Correlation Between Cullinan Oncology and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and C4 Therapeutics, you can compare the effects of market volatilities on Cullinan Oncology and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and C4 Therapeutics.
Diversification Opportunities for Cullinan Oncology and C4 Therapeutics
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cullinan and CCCC is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Cullinan Oncology and C4 Therapeutics
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the C4 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 1.12 times less risky than C4 Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The C4 Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 385.00 in C4 Therapeutics on October 20, 2024 and sell it today you would earn a total of 9.00 from holding C4 Therapeutics or generate 2.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. C4 Therapeutics
Performance |
| Timeline |
| Cullinan Oncology LLC |
| C4 Therapeutics |
Cullinan Oncology and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and C4 Therapeutics
The main advantage of trading using opposite Cullinan Oncology and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Foghorn Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |